DOI: https://doi.org/10.14710/jekk.v6i2.9140

Small Interfering RNA (siRNA) of Mini circle DNA Transfection (McD) is Encapsulated by Gold Nanoparticles from Folate’s Receptors of Gold Conjugation as Curative Therapy for Non-Small’s Cell of Lung Cancer

*agung wiwiek indrayani orcid scopus  -  Universitas Udayana, Indonesia
I Gusti Ayu Sitti Sadvika  -  Universitas Udayana, Indonesia
I Gede Wikania Wira Wiguna  -  Universitas Udayana, Indonesia
Ni Putu Sri Indrani Remitha  -  Universitas Udayana, Indonesia
I Gede Krisna Arim Sadeva  -  Universitas Udayana, Indonesia
Anak Agung Bagus Putra Indrakusuma  -  Universitas Udayana, Indonesia
Putri Ayu Wulandari  -  Universitas Udayana, Indonesia
Ni Wayan Sucindra Dewi  -  Universitas Udayana, Indonesia

Citation Format:
Abstract

Background: Lung cancer is one of the non-communicable diseases that have an increasing number of events that each year with a mortality rate of 18.4% and an incidence of 11.6%, occupies the top position based on GLOBOCAN data in 2018. One of management in the NSCLC is currently in the form of surgery and adjuvant therapy such as chemotherapy, radiotherapy and target therapy. However, there were weaknesses and limitations in care for its patients therefore development of curative therapy for NSCLC’s patients were needed.  The aim of this review is to learn and investigate about the potential of siRNA that is transfected into McD and folate receptors alpha-conjugated gold nanoparticle encapsulation as a therapeutic opportunity that could be developed as a treatment in management of NSCLC.

Method: The writing method used in this review article was the study method of literature.  The used data comes from 45 of relevant literature sources and was arranged systematically in accordance with the topic of the problem discussed, along with the inclusion and exclusion criteria.

Result: This treatment could increase gene transfection, siRNA biodistribution in organs, reduced KRAS, Bcl-2, and VEGF expression.  Moreover, siRNA had entered phase III clinical trials and FOLR1 antibodies were in phase II of clinical trials.

Conclusion: Utilization of siRNA specifically was designed for three genes such for KRAS, VEGF and Bcl-2 which were three genes that played a role in the pathogenesis of NSCLC, could be the right modality choice for treatment of NSCLC.

 

Fulltext View|Download
Keywords: NSCLC; small interfering RNA; gold nanoparticle; minicircle DNA; FOLR1.

Article Metrics:

Article Info
Section: Articles
Language : EN
Recent articles
Kolaborasi Perawat dan Ahli Gizi dalam Penanganan Masalah Gizi Balita di Wilayah Kerja Puskesmas Halmahera Barat. Small Interfering RNA (siRNA) of Mini circle DNA Transfection (McD) is Encapsulated by Gold Nanoparticles from Folate’s Receptors of Gold Conjugation as Curative Therapy for Non-Small’s Cell of Lung Cancer Pengaruh Konsumsi Air dan Keberadaan Fasilitas Sanitasi terhadap Angka Diare pada Anak-Anak di Indonesia More recent articles
  1. Alto, P. 2017. Mini Circle DNA Technology. System Biosciences. 7:1-30
  2. Cheung, A., Bax, H.J., Josephs, D.H., Ilieva, K.M., Pellizari, G., Opzoomer, J., Bloomfield, J. 2016. Taegeting Folate Receptor Alpha for Cancer Treatment. Oncotarget. 7(32):52553-52569
  3. Chabot, S., Orio, J., Schmeer, M., Schleef, M., Golzio, M., Teissie, J. 2012. Minicircle DNA Electrotransfer for Efficient Tissue-Targeted Gene Delivery. Gene Therapy.1-7
  4. Chong, C.R., Janne, P.A. 2013.The Quest to Overcome Resistance to EGFR-Targeted Therapies in Cancer. Nat Med.19(11):1389–400
  5. Chakraborty, C., Sharma, A.R., Sharma, G., Doss, C., & Lee, S.S. 2017. Therapeutic miRNA and siRNA, Moving from Bench to Clinic as Next Generation Medicine. Molecular therapy. Nucleic acids. 8:132–143
  6. Chen, P., Cheng, H., Wang, J., Wang, S. 2014. Prostate Cancer-Derived CCN3 Induces M2 Macrophage Infiltration and Contributes to Angiogenesis in Prostate Cancer Microenvironment. Oncotarget. 5(6):1595–608
  7. Dana, H., Chalbatani, G.M., Mahmoodzadeh, H., Karimloo, R., Rezaiean, O., Moradzadeh, A. 2017. Molecular Mechanisms and Biological Functions of siRNA. International Journal of Biomedical Science.13(2):48-53
  8. De Groot, P., Reginald, F., Munden. 2012. Lung Cancer Epidemiology, Risk Factors, and Prevention. Radiol Clin N Am Elsevier:863–876
  9. Deb, S., Patra, H.K., Lahiri, P., Dasgupta, A.K., Chakrabarti, K., Chaudhuri, U. 2011. Multistability in Platelets and Their Response to Gold Nanoparticles. Nanomed: Nanotechnol Biol Med. 7:376-384
  10. Epanchintseva, A.,S., Poletaeva, J.,E., Pyshnyi, D.,V., Ryabchikova, E.,I., Pyshnaya, I.,A. 2019. Long-Term Stability and Scale-Up of Noncovalently Bound Gold Nanoparticle-siRNA Suspensions. Beilstein Journal of Nanotechnology. 10:2568-2578
  11. Fakhr, E., Zare, F., Teimoori-Toolabi, L. 2016. Precise and Efficient siRNA Design, A Key Point in Competent Gene Silencing. Cancer Gene Therapy:1-10
  12. Ferlay, J., Colombet, M., Soerjomataram, I., Mathers, C., Parkin, D.M., Piñeros, M., Znaor, A., Bray, F. 2018. Estimating the Global Cancer Incidence and Mortality in 2018: GLOBOCAN Sources and Methods. International Journal of Cancer. 144(8):1941-1953
  13. Figg, K.M.C. 2011. Angiogenesis Inhibitors-Current Strategies and Future Prospects. 60:222-243
  14. Frezzetti, D., Gallo, M., Maiello, M.R., D’Alessio, A., Esposito, C., Chicchinelli, N. 2017. VEFG as Potential Target in Lung Cancer. Expert Opinion on Therapeutic Targets. 21(10):959-966
  15. Guo, Q., Yuan, J., Zeng, J. 2014. Biosynthesis of Gold Nanoparticles Using a Kind of Flavonol: Dihydromyricetin Colloids and Surfaces A: Physicochemical and Engineering Aspects. 441:127-132
  16. Huang, C., Ju, D., Chang, C., Reddy, P.M., Velmurugan, B.K. 2017. A Review on The Effects of Current Chemotherapy Drugs Natural Agents in Treating Non-Small Cell Lung Cancer. Biomedicine. 7(4):12-23
  17. Huang, Y., Cheng, Q., Ji, J., Zheng, S., Du, L., Meng, L., Wu, Y., Zhao, D., Wang, X., Lai, L., Cao, H., Xiao, K., Gao, S., Liang, Z. 2016. Pharmacokinetic Behaviors of Intravenously Administered siRNA in Glandular Tissue. Theranostic. 6(10):1528-1541
  18. Jafari, S.M., Yazdi, F., Masoomi, K.M., Alizadeh, J., Rahmati, M., Zarei, M.A. 2016. The siRNA-Mediated Down-Regulation of Vascular. Marranci. 10(6): 316–26
  19. Lewandowska, M.A. 2013. KRAS and BRAF Mutation Analysis in Colorectal Adenocarcinoma Specimens with a Low Percentage of Tumor Cells. Original Research Article. 17:193-203
  20. Lee, T., Jeong, E., Min, I.J., Kim, S.Y., Kim, H.R., Kim, C.H. 2017. Altered Expression of Cellular Proliferation, Apoptosis and The Cell Cycle-Related Genes in Lung Cancer Cells with Acquired Resistance to EGFR Tyrosine Kinase Inhibitors. Oncol Lett. 14:2191–7
  21. Lin, S.A.M.H., Luidens, M.K., Davis, P.J. 2014. Modulation of Angiogenesis by Thyroid Hormone and Hormone Analogues , Implications for Cancer Management. Angiogenesis:1–7
  22. Lan, M.Y., Hsu, Y.B., Hsu, C.H., Ho, C.Y., Lin, J.C., Lee, S.W. 2013. Induction of Apoptosis by High-Dose Gold Nanoparticles in Nasopharyngeal Carcinoma Cells. Auris Nasus Larynx. 40:563-568
  23. Maniar, L.E.G., Maniar, J.M., Chen, Z., Lu, J., Fire, A.Z., Kay, M.A. 2013. Minicircle DNA Vectors Achieve Sustained Expression Reflected by Active Chromatin and Transcriptional Level. Molecular Therapy. 21(1):131-138
  24. Mishra, A., Tripathy, S.K., Yun, S.I. 2012. Fungus Mediated Synthesis of Gold Nanoparticles and Their Conjugation with Genomic DNA Isolated from Escherichia coli and Staphylococcus aureus. Process Biochem. 47:701-711
  25. Min, S.S., Young, J.K. 2010. Efficient and Targeted Delivery of siRNA In Vivo. FEBS Journal:4814-4827
  26. Geng, Z., Zhang, M., Pan, X., Wang L. 2013. Bcl-2 Gene Silencing by RNA Interference Inhibits The Growth of The Human Gallbladder Carcinoma Cell Line GBC-SD In Vitro and In Vivo. Oncology Reports. 30:793-800
  27. Pecot, C.V., Wu, S.Y., Bellister, S., Filant, J., Rupaimoole, R., Hisamatsu, T., Nagaraja, A.S. 2014. Therapeutic Silencing of KRAS Using Systemically Delivered SiRNAs. Molecular Cancer Therapeutics. 13(12):2876-2885
  28. Ping-Li, S., Hironobu, S., Hongwen, G. 2017. Bcl-2 Family in Non-Small Cell Lung Cancer: Its Prognostic and Therapeutic Implications. Pathology International:1-10
  29. Rahman, M.M., McFadden, G. 2011. Modulation of NF-κB Signalling by Microbial Pathogens. NIH Public Access. 9(4):291–306.rini
  30. Reuveni, T., Motiei, M., Romman, Z., Popovtzer, A., Popovtzer, R. 2011. Targeted Gold Nanoparticles Enable Molecular CT Imaging of Cancer: An In Vivo Study. International Journal of Nanomedicine. 6:2859–2864
  31. Rini, C., Widjajanto, E., Loekito, R. 2011. Peranan Curcumin terhadap Proliferasi, Apoptosis dan Diferensiasi Hepatosit Mice Balb / C yang Dipapar dengan Benzapyrene. JExp Life Sci. 1(2):64–71
  32. Samadian, dkk. 2016. Folate-Conjugated Gold Nanoparticle as a New Nanopaltform for Targeted Cancer Therapy. J Cancer Res Clin Oncol. 142(11):2217-2229
  33. Sari, L.M. 2018. Apoptosis, Mekanisme Molekuler Kematian Sel. Cakradonya Dent J. 10(2): 65–70
  34. Sholih, M.G., Perwitasari, D.A., Hendriani, R., Sukandar, H., Barliana, I., Suwantika, A. et.al. 2019. Risk Factor of Lung Cancer in Indonesia. 2019 Journal of Advanced Pharmacy Education & Research. 9(2): 41-45
  35. Son, S., Kim, N., You, D.,G., Yoon, H.,Y., dkk. 2017. Antitumor Therapeutic Application of Self-Assembled RNAi-AuNP Nanoconstructs: Combination of VEGF-RNAi and Photothermal Ablation. Theranostic. 7(1): 9-22
  36. Takeuchi, I., Nobata, S., Oiri, N., Tomoda, K., Makino, K. 2017. Biodistribution and Excretion of Colloidal Gold Nanoparticles After Intravenous Injection: Effects of Particle Size. Bio-Medical Materials and Engineering. 28: 315–323
  37. Takeuchi, I., Onaka, H., Makino, K. 2018. Biodistribution of Colloidal Gold Nanoparticles After Intravenous Injection: Effects of PEGylation at The Same Particle Size. Bio-Medical Materials and Engineering. 29:205–215
  38. Tekedereli, I., Alpay, S.N., Akar, U., Yuca, E., Ayugo-Rodriguez, C., Han, H., Sood, A.K., Lopez-Berestein, G., Ozpolat, B. 2013. Therapeutic Silencing of Bcl-2 by Systemically Administered siRNA Nanotherapeutics Inhibits Tumor Growth by Autophagy and Apoptosis and Enhances the Efficacy of Chemotherapy in Orthotopic Xenograft Models of ER (−) and ER (+) Breast Cancer. Molecular Therapy—Nucleic Acids. 2(121):2162-2531
  39. Tobacco Control Support Centre-IAKMI, Kementerian Kesehatan. 2012. Bunga Rampai Fakta Tembakau dan Permasalahannya di Indonesia Tahun 2012. Jakarta: Tobacco Control Support Centre-IAKMI
  40. Verma, P.,Thakur, A.S., Deshmukh, K., Jha A.K., Verma, S. 2010. Routes of Drug Administration. International Journal of Pharmaceutical Studies and Research. 1(1):54-59
  41. Wong, R.S.Y. 2011. Apoptosis in Cancer , From Pathogenesis to Treatment. J Exp Clin Cancer Res. 30(1):87
  42. Xu, L., Stevens, J., Hilton, M.B., Seaman, S., Conrads, T.P., Veenstra, T.D. 2018. COX-2 Inhibition Potentiates Anti-Angiogenic Cancer Therapy and Prevents Metastasis in Preclinical Models. Sci Transl Med. 6(242):1–24
  43. Yuan, D., Xia, M., Meng, G., Xu, C., Song, Y., Wei, J. 2015. Anti-Angiogenic Efficacy of 5′-Triphosphate SiRNA Combining VEGF Silencing and RIG-I Activation in NSCLCs. Oncotarget. 6(30):29664-29674
  44. Zhang, J. 2014. Intratumor Heterogeneity in Localized Lung Adenocarcinomas Delineated by Multiregion Sequencing. Science. 346: 256–259
  45. Zhang, Z., dkk. 2010. Conjugation Folic Acid to Gold Nanoparticle Through Glutathione for Targeting and Detecting Cancer Cells. Bioorganic Med Chem. 18(15):5528-5534

Last update:

No citation recorded.

Last update:

No citation recorded.